1-155942410-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181885.3(RXFP4):c.701G>A(p.Arg234Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000214 in 1,552,768 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181885.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXFP4 | NM_181885.3 | c.701G>A | p.Arg234Gln | missense_variant | 1/1 | ENST00000368318.5 | NP_871001.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXFP4 | ENST00000368318.5 | c.701G>A | p.Arg234Gln | missense_variant | 1/1 | 6 | NM_181885.3 | ENSP00000357301.4 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000217 AC: 44AN: 203168Hom.: 0 AF XY: 0.000195 AC XY: 21AN XY: 107960
GnomAD4 exome AF: 0.000218 AC: 306AN: 1400618Hom.: 1 Cov.: 32 AF XY: 0.000231 AC XY: 159AN XY: 688746
GnomAD4 genome AF: 0.000177 AC: 27AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.701G>A (p.R234Q) alteration is located in exon 1 (coding exon 1) of the RXFP4 gene. This alteration results from a G to A substitution at nucleotide position 701, causing the arginine (R) at amino acid position 234 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at